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Slc15a1 is involved in the transport 
of synthetic F5-peptide into the 
seminiferous epithelium in adult 
rat testes
Linlin Su1,*, Yufei Zhang2,*, Yan C. Cheng3, Will M. Lee4, Keping Ye5 & Dahai Hu1
Spermiation and BTB restructuring, two critical cellular events that occur across seminiferous 
epithelium in mammalian testis during spermatogenesis, are tightly coordinated by biologically 
active peptides released from laminin chains. Our earlier study reported that F5-peptide, synthesized 
based on a stretch of 50 amino acids within laminin-γ3 domain IV, could reversibly induce the 
impairment of spermatogenesis, disruption of BTB integrity, and germ cell loss, and thus is a 
promising male contraceptive. However, how F5-peptide when administered intratesticularly enters 
seminiferous tubules and exerts effects beyond BTB is currently unknown. Here we demonstrated 
that Slc15a1, a peptide transporter also known as Pept1, was predominantly present in peritubular 
myoid cells, interstitial Leydig cells, vascular endothelial cells and germ cells, while absent in Sertoli 
cells or BTB site. The steady-state protein level of Slc15a1 in adult rat testis was not affected by 
F5-peptide treatment. Knockdown of Slc15a1 by in vivo RNAi in rat testis was shown to prevent F5-
peptide induced disruptive effects on spermatogenesis. This study suggests that Slc15a1 is involved 
in the transport of synthetic F5-peptide into seminiferous epithelium, and thus Slc15a1 is a novel 
target in testis that could be genetically modified to improve the bioavailability of F5-peptide as a 
prospective male contraceptive.
During spermatogenesis in the mammalian testis, two key cellular events, namely spermiation and BTB 
restructuring, that occur at the opposite ends of the seminiferous epithelium are coordinated by biolog-
ically active laminin peptides1. Studies from other epithelia have also demonstrated that laminin frag-
ments are biologically active, capable of altering cellular function, including cell movement and cell 
adhesion2–6. Our recent study has identified such a laminin-γ 3-derived fragment designed as F5 that 
can induce the impairment of spermatogenesis7. Local administration of the synthetic peptide F5 which 
is composed of 50 amino acids into rat testes was found to cause BTB disruption and germ cell loss7, 
suggesting this laminin peptide fragment may serve as a contraceptive in male rats. However, as the syn-
thetic F5-peptide was administered via direct intratesticular injection, the way how it enters seminiferous 
tubules and plays further roles beyond the BTB remains unknown.
Peptides are essential in nutrition, and certain peptides serve as important signaling molecules8–10. 
The entrance of peptides into cells/tissues often requires transporter-mediated processes11. Slc15a1 (sol-
ute carrier family 15, member 1), also known as the peptide transporter 1 (Pept1), is predominantly 
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expressed in small intestine12, testis, kidney, liver and brain13, and is believed to play key roles in intestinal 
absorption and renal reabsorption of di- and tri-peptides14. As a low-affinity, high-capacity transporter, 
Slc15a1 has broad substrate requirement and tolerates diverse chemical modification, and therefore 
accepts various chemicals as substrates14. In addition to the transport of endogenous peptides, Slc15a1 
also transports exogenous synthetic peptides and various peptide-like drugs, including β -lactam antibi-
otics, angiotensin converting enzyme (ACE) inhibitors, renin inhibitors, thrombin inhibitors, and the 
aminopeptidase inhibitor bestatin15. Slc15a1 is shown to be a promising target for facilitating intestinal 
absorption of prodrugs16, thus we are interested to know whether Slc15a1 is also involved in the transport 
of F5, a 50-amino acid polypeptide and potential male contraceptive, into the seminiferous epithelium.
We here report the demonstration of Slc15a1 as a potential carrier for the synthetic F5-peptide. In the 
present study, the cellular expression and localization of Slc15a1 in rat testes have been investigated for 
the first time. Local knockdown of Slc15a1 in rat testes by in vivo RNAi has shown to impede F5-peptide 
induced impairment of spermatogenesis, germ cell loss, and BTB disruption.
Results
Slc15a1 exists in adult rat testes, germ cells, peritubular myoid cells and interstitial Leydig 
cells, but not in Sertoli cells. The expression of Slc15a1 in various organs including the testes was 
demonstrated by RT-PCR as described previously12,13. The current study further explored the cellular 
expression of Slc15a1 in testes using Slc15a1-specific primer pair as shown in Table 1. The transcript of 
Slc15a1 was detected in adult rat testes, germ cells, myoid cells and Leydig cells, while not detectable 
in Sertoli cells (Fig. 1A). The protein level of Slc15a1 was ~5-fold higher in lysates of testes than that in 
germ cells, and ~1.3-fold higher in myoid cells or Leydig cells than that in testes, while absent in Sertoli 
cells (Fig. 1B) when assessed by Western blot with a specific anti-Slc15a1 antibody as shown in Table 2. 
These results corroborated reports in the literature that testis is equipped with Slc15a112,13.
Slc15a1 locates at tunica propria, interstitium, blood vessel endothelia and germ cell nuclei 
in rat testes. Enzyme immunohistochemistry revealed that Slc15a1 neither located to the site of BTB 
at all stages of seminiferous epithelial cycle in adult rat testes, nor to the lumenal edge surrounding elon-
gated spermatids at stages VII-VIII at the site of apical ectoplasmic specialization [apical ES] (Fig. 2B–D), 
two critical ultrastructures securing normal spermatogenesis. Instead, strong Slc15a1 immunoreactiv-
ity was detected outside of the seminiferous epithelium at tunica propria (i.e., peritubular myoid cells, 
noted by green arrowheads), interstitium (i.e., Leydig cells, noted by red arrowheads) and blood vessel 
endothelium (Fig.  2B–D). A significantly weaker signal was also observed in the nuclei of germ cells 
(Fig. 2B–D, noted with blue asterisks). Incubating sections with normal rabbit IgG at the same dilution 
as used for Slc15a1 IgG yielded no observable staining (Fig. 2A). The monospecificity of Slc15a1 anti-
body was assessed by immunoblotting and a single 75 kD protein band was observed in testis lysates 
(Fig. 2E), illustrating that this antibody is suitable for enzyme immunohistochemistry and immunoflu-
orescent microscopy experiments. Immunofluorescent staining on adult rat testes revealed that Slc15a1 
failed to colocate with BTB tight junction (TJ) marker ZO-1 (Fig. 2F) or adhesion junction (AJ) marker 
N-cadherin (Fig.  2G), further supporting its absence at the BTB. Instead, the fluorescence signal of 
Slc15a1 was detected beneath the BTB at tunica propria, interstitium and blood vessel endothelia, and 
also distributed as scattered spots at the nuclei of germ cells (Fig. 2F,G).
Local administration of synthetic F5-peptide intratesticularly does not affect the steady-state 
level of Slc15a1 in adult rat testes. A previously established in vivo model for spermatogenesis 
impairment was used7 to correlate the function of Slc15a1 and peptide transport in the testis. Treating 
adult rat testis with the synthetic F5-peptide was found to cause reversible BTB disruption and germ 
cell loss7. Slc15a1 is known as an oligopeptide transporter and responsible for peptide absorption in the 
small intestine17. Thus, we were interested to know whether Slc15a1 was also involved in the transport 
of F5-peptide into the seminiferous tubules in rat testis. We examined the steady-state level of Slc15a1 in 
adult rat testis after F5-peptide treatment by immunoblotting (Fig. 3A), and found that F5-peptide did 
not cause the level change of Slc15a1 up to 5 days post-treatment (Fig. 3B).
Gene Primer sequence Orientation Position
Length 
(bp)
A.T. 
(°C)
Cycle 
no.
GenBank® accession no.
Slc15a1 5′ - CTCTGCTACCTGACTCCAA-3′ sense 184–202 223 53 25 NM_057121
5′ - TACCAAGGGCTATCAGGG-3′ anti-sense 389–406
S-16 5′ - TCCGCTGCAGTCCGTTCAAGTCTT-3′ sense 15–38 385 53 25 XM_341815
5′ - GCCAAACTTCTTGGTTTCGCAGCG-3′ anti-sense 376–399
Table 1.  Primers used for RT-PCR in this study. A.T., annealing temperature.
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The steady-state level of Slc15a1 is effectively inhibited by in vivo RNAi in rat testes. To 
demonstrate the involvement of Slc15a1 in transporting F5-peptide that further induces the impairment 
of spermatogenesis, we performed in vivo RNAi on day 0 to specifically knockdown Slc15a1 expression 
Figure 1. Expression of Slc15a1 in adult rat testes. (A) Gene expression of Slc15a1 in adult rat testes 
(T), Sertoli cells (SC), germ cells (GC), peritubular myoid cells (MC), and interstitial Leydig cells (LC) was 
analyzed by RT-PCR. S-16 served as a control. M, DNA ladder marker. (B) Immunoblotting of Slc15a1 
in lysates of T, SC, GC, MC, and LC (∼ 50 μ g proteins/lane) with actin as a loading control. Histogram 
summarizes the immunoblot results after normalizing each data point against corresponding actin. Slc15a1 
protein level in the testis was arbitrarily set as 1. Bars represent means ± SD, n = 3. *P < 0.05, **P < 0.01. 
n.s., not detectable.
Antigen Catalog no. Immunogen Host Vendor
Dilution
IB IHC IF
Slc15a1 LS-C18855
Synthetic peptide 
corresponding to human 
SLC15A1;
Rabbit Lifespan biosciences 1:1000 1:50 1:50
sc-20653
Epitope corresponding to 
amino acids 366-600 of 
PEPT1 of human origin
Rabbit Santa cruz biotechnology 1:200
ZO-1 61-7300
Fusion protein 
corresponding to amino acid 
residues 463-1109 of human 
ZO-1
Rabbit Zymed/Invitrogen 1:50
N-Cadherin sc-7939 Amino acid residues 450-512 of human N-cadherin Rabbit Santa cruz biotechnology 1:50
Actin sc-1616 Peptide mapping of C-terminus of human actin Goat Santa cruz biotechnology 1:200
Table 2.  Summary of primary antibodies used in this study. IB, immunoblotting; IHC, 
immunohistochemistry; IF, immunofluorescence.
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in rat testes (n = 9) (Fig. 4A). Two days thereafter (day 2), testes from 3 rats were removed and lysed for 
immunoblotting, results showed an ~90% decrease in the protein level of Slc15a1 after RNAi (Fig. 4B). 
F5-peptide at 320 μ g/testis was then immediately administered to the remaining 6 rats via intratesticu-
lar injection following the confirmation of effective Slc15a1 knockdown. Three days thereafter (day 5), 
testes from 3 rats were harvested for immunoblotting to examine Slc15a1 level or HE staining, or used 
for BTB integrity assay (n = 3) in the following experiments. Importantly, lysates from day-5 testes still 
showed a 75% reduction on Slc15a1 level, demonstrating a relatively stable gene knockdown by in vivo 
RNAi (Fig. 4B).
Slc15a1 knockdown prevents F5-peptide induced disruption of BTB integrity in vivo. We 
next sought to examine the role of Slc15a1 in F5-peptide induced BTB disruption by in vivo BTB integ-
rity assay. In control rat testes, FITC-inulin (green fluorescence) administered to rats at the jugular 
vein was found to be excluded from entering the adluminal compartment of the epithelium (Fig. 5A), 
Figure 2. Cellular localization of Slc15a1 in the seminiferous epithelium of adult rat testes. (A) 
Immunohistochemistry was performed using frozen testis sections. Primary antibody was replaced with 
normal rabbit IgG as negative control. (B–D) Specific staining for Slc15a1 appears as brownish-red 
precipitates. Green arrowheads point to peritubular myoid cells, red arrowheads point to interstitial Leydig 
cells, blue asterisks indicate Slc15a1-stained nuclei of germ cells, ‘bv’ represents blood vessel. Roman 
numerals indicate tubule stages. Nuclei were stained with hematoxylin. Scale bars = 150 μ m in (A,B), 
100 μ m in (C,D). (E) Specificity of the anti-Slc15a1 antibody as demonstrated by an immunoblot of testis 
lysate (∼ 50 μ g protein). M, protein ladder marker. (F,G) Immunofluorescent microscopy was performed 
on frozen testis sections. Co-localization of Slc15a1 (red) with tight junction (TJ) marker ZO-1 (green) or 
adhesion junction (AJ) marker N-cadherin (green) in the adult rat testis was shown in F and G, respectively. 
Corresponding merged images were also shown, but no area of co-localization was observed (no orange 
color). Roman numerals indicate tubule stages. Nuclei were stained with DAPI (blue). Scale bars = 100 μ m. 
Experiments were repeated three times using testes from three rats.
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Figure 3. Changes in the steady-state level of Slc15a1 in F5-peptide treated rat testes. Adult rat testes 
were topically injected with a synthetic peptide F5 to induce the impairment of spermatogenesis. (A) 
Immunoblots of Slc15a1 in 0 h, 12 h, 1 d, 2 d, 3 d, 4 d and 5 d testis lysates following F5 treatment, with actin 
as a loading control. (B) Histogram summarizing results after normalizing each data point against actin. The 
value at 0 h was arbitrarily set as 1. Bars are means ± SD; n = 3. 1-way ANOVA followed by Dunnett’s test.
Figure 4. The in vivo RNAi of Slc15a1 in adult rat testes. (A) The regimen used in this study. Briefly, 
the right testes of rats (n = 9) were injected with 100 nM Slc15a1 siRNA duplexes, while the left ones were 
treated with 100 nM non-targeting control siRNA on day 0. Two days later (day 2), 3 rats were killed and 
their testes were removed and lysed for immunoblotting to examine the silencing effect of Slc15a1 RNAi.  
F5-peptide at 320 μ g/testis was then injected to each testis of the remaining 6 rats. Three days thereafter  
(day 5), 3 rats were sacrificed and their testes were harvested for immunoblotting and HE staining, while 
the remaining 3 rats were subject to BTB assay. (B) Representative immunoblots illustrating an ∼ 90% and 
∼ 75% knockdown of Slc15a1 in the testes on day 2 and day 5 respectively after transfection with siRNA 
duplexes. C) Densitometric analysis of Slc15a1 immunoblotting data normalized against actin with the 
control arbitrarily set at 1. Each bar is the mean ± SD of three experiments, **P < 0.01.
www.nature.com/scientificreports/
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consistent with the presence of a functional BTB located near the basement membrane. In rats treated 
with F5-peptide at dose of 320 μ g/testis, BTB integrity was compromised (Fig.  5B), even though this 
damage was not as severe as the CdCl2-induced irreversible BTB disruption7. However, when testes 
were pre-transfected with Slc15a1 siRNA duplexes to specifically suppress Slc15a1 expression, F5-peptide 
was found to lose its capability to induce BTB damage (Fig.  5D). Testes receiving both non-targeting 
siRNA duplexes and F5-peptide showed no difference with those treated with F5-peptide alone (Fig. 5C). 
Findings shown in Fig. 5A–D were further analyzed semi-quantitatively by comparing the distance trav-
eled by FITC-inulin beyond the BTB near the basement membrane (DFITC) versus the radius of the 
seminiferous tubule (DSTr) (Fig. 5E).
Slc15a1 knockdown blocks F5-peptide induced impairment of spermatogenesis in vivo. We 
then moved to examine the role of Slc15a1 in F5-peptide induced impairment of spermatogenesis in rats. 
Synthetic F5-peptide at 320 μ g/testis was administered via intratesticular injection, and histological anal-
ysis was performed following hematoxylin and eosin staining using cross-sections of paraffin-embedded 
testes (Fig. 6A–D). Histological analysis of these testes revealed that synthetic F5-peptide caused germ 
cell depletion from the epithelium, mostly on elongated, elongating or round spermatids and some late 
spermatocytes in treatment (Fig.  6B) vs. control (Fig.  6A). However, when testes were pre-transfected 
with Slc15a1 siRNA duplexes to specifically suppress Slc15a1 expression, F5-peptide was found to lose its 
capability to induce germ cell loss (Fig. 6D) vs. that in non-targeting siRNA pre-treated testes (Fig. 6C). 
Figure 5. Effect of Slc15a1 knockdown on F5-peptide induced disruption of BTB integrity in rat testes. 
BTB integrity assay was performed to assess the ability of an intact BTB to block the movement of FITC-
inulin across the BTB from the basal compartment near the basement membrane (annotated by “white” 
dotted line) to the adluminal compartment. Results of the BTB integrity assay were shown in normal testis 
(Ctrl, A), testis treated with F5-peptide at 320 μ g/testis (F5, B), or testis pre-transfected with non-targeting 
control siRNA (Ctrl RNAi+ F5, C) or Slc15a1 siRNA (Slc15a1 RNAi+ F5, D). Scale bar = 150 μ m. (E) 
Histogram summarizing data based on findings shown in (A–D) by comparing the distance of FITC-inulin 
diffused into the epithelium (DFITC) (annotated by the “white bracket”) vs. the radius of a seminiferous 
tubule (DSTr) (the average of the longest and shortest semi-axes for sections of oval-shaped tubules) (n = 200 
tubules from testes of 3 rats in each group). **P < 0.01.
www.nature.com/scientificreports/
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Above treatments did not elicit statistically significant changes in testis weight since cell adhesion was 
affected in only ~20% of the tubules examined (Fig. 6E,F). The tubule diameter was reduced by ~20% 
(Fig. 6E,F) in ~20% of the tubules randomly scored, consistent with the observations shown in Fig. 6A–D.
Discussion
The primary aim of this study is to determine whether Slc15a1 is a potential carrier involved in the 
transport of synthetic F5-peptide into the seminiferous epithelium where this peptide exerts its physio-
logical functions such as inducing BTB disruption and germ cell loss7. RT-PCR (Fig. 1A) and Western 
blot (Fig. 1B) results revealed Slc15a1 was expressed by the testes, in accordance with earlier reports12,13. 
However, Slc15a1 was also detectable in germ cells, myoid cells and Leydig cells, but not in Sertoli cells 
(Fig.  1A,B), which was in contrast with the distribution pattern of P-gp and MRP1, two best-studied 
drug transporters in the testes where they were predominantly expressed by Sertoli cells13,18, suggesting 
their distinctive physiological functions in the testes. In order to obtain a more visual understanding 
on Slc15a1’s distribution in the testis at the cellular level, an enzyme immunohistochemistry was per-
formed and results illustrated that Slc15a1 apparently located at tunica propria (i.e., peritubular myoid 
cells), interstitium (i.e., Leydig cells) and blood vessel endothelium (Fig. 2B–D), relatively weaker signals 
were also detected in the nuclei of germ cells at all stages of seminiferous epithelial cycle (Fig. 2B–D). 
Immunofluorescence microscopy further validated above observation and again confirmed the absence 
of Slc15a1 at the BTB since it failed to co-localize with BTB constituent marker ZO-1 or N-cadherin 
(Fig. 2F–G). This is the first report on Slc15a1’s precise cellular localization in testes and is the basis for 
the following functional studies.
Figure 6. Effect of Slc15a1 knockdown on F5-peptide induced impairment of spermatogenesis and germ 
cell loss in rat testes. (A) Representative photographs of paraffin sections of testes stained with hematoxylin 
and eosin. Results of HE staining were shown in normal testis (Ctrl, A), testis treated with F5-peptide at 
320 μ g/testis (F5, B), or testis pre-transfected with non-targeting control siRNA (Ctrl RNAi+ F5, C) or 
Slc15a1 siRNA (Slc15a1 RNAi+ F5, D) of a group of adult rats (~300–350 gm b.w.) with n = 3 rats in each 
treatment group. Scale bar in A–D = 150 μ m. The “blue” and “green” encircled micrographs are magnified 
images of the corresponding boxed areas of the lower magnification, bar = 50 μ m. (E,F) Morphometric 
changes of seminiferous tubules (ST) (n = 200 tubules from 3 rat testes). The shrinkage of tubules indicated 
by changes in ST diameter (the average ST diameter in treatment group vs. that in its corresponding control) 
(E), and the percentage of damaged ST number manifested by germ cell exfoliation (annotated by asterisks 
in tubules seen in B,C) in treatment group vs. that in its corresponding control (F) are summarized in the 
bar graphs (E,F), respectively. *P < 0.05, **P < 0.01 when compared to normal control rats.
www.nature.com/scientificreports/
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Tunica propria functions as one of the major protective barriers in the testes that defends the entrance 
of harmful or unwanted substances19. It is worth noting that Slc15a1 predominantly localized to peritu-
bular myoid cells (Fig. 2B–D), this is interesting because in rodents peritubular myoid cells are known 
to contribute, at least to some extent, to BTB function19,20. As such, it is possible that myoid cells also 
function in the protection of seminiferous epithelium against unwanted agents and drugs. Regarding 
Slc15a1 as an influx peptide transporter and its strong tunica propria localization surrounding seminif-
erous tubules, we assumed that Slc15a1 might be involved in transporting exogenous substances, such 
as the synthetic F5-peptide into seminiferous epithelium where it took further actions. To validate this 
hypothesis, we next performed in vivo Slc15a1 gene silencing in rat testes to examine whether knock-
down of Slc15a1 would prevent or promote F5-peptide induced impairment of spermatogenesis.
Following the local injection of synthetic F5-peptide into rat testes, no significant change on the 
steady-state protein level of Slc15a1 was observed up to 5 days post-treatment (Fig. 3). Generally speak-
ing, the up-regulation of transporter proteins such as P-gp13 or oatp321 in the testis following drug 
stimulation is often observed and results in the acceleration of substrate efflux or influx. However, the 
maintenance of steady-state level of Slc15a1 upon F5 stimulation does not necessarily mean that Slc15a1 
could not be a potential transporter for F5-peptide, since the expression level of transporter proteins 
cannot solely reflect their transport capacity. In addition, F5-peptide administration also did not sig-
nificantly affect the result of Slc15a1 knockdown (Fig. 4B). When Slc15a1 was pre-silenced in rat testis 
by in vivo RNAi, F5 failed to induce any changes as the testis showed the same normal BTB integrity 
(Fig. 5D) and morphology (Fig. 6D) as the untreated control testis (Figs 5A and 6A). The disruption of 
BTB integrity (Fig.  5C), germ cell loss, shrinkage of seminiferous tubule, and impairment of spermat-
ogenesis (Fig. 6C) were all observed in non-targeting siRNA-pretreated testis, suggesting that a unique 
mechanism involving Slc15a1 is in place to transport F5-peptide into the seminiferous epithelium and 
exert function beyond the BTB site. The presence of influx transporter at tunica propria for F5-peptide 
well explains a previous question that why administering F5-peptide basally to rat testes in vivo would 
take effects since the receptor for F5-peptide if exists would presumably be concentrated above the BTB7. 
As the anti-F5 antibody or the fluorescence-tagged F5-peptide is currently unavailable commercially, we 
are making every effort to prepare, purify and test an antibody for F5-peptide with high specificity and 
purity. Investigation on the uptake of F5-peptide into myoid cells or basal compartment with the use of 
an anti-F5-peptide antibody will strongly support above hypothesis.
Protein and long peptide normally need to be hydrolyzed into short fragments, such as di- or 
tri-peptide for the intestinal absorption via Slc15a1. While in the testis our results show that the intact 
F5-peptide, 50 amino acids in length, could also be a substrate and transported via Slc15a1. This is not 
unpredictable since oligopeptides serve as nutrient substance in intestinal tract, while F5-peptide func-
tions most probably as a signaling molecule in the testis and thus it does not need to and even cannot 
be shortened. The present study has revealed that the efficacy via local administration of F5-peptide 
in the testis is only ~20% (Figs 5E and 6E,F), the highest up to ~40%7. Thus, the gene modification or 
the protein spatial re-conformation of Slc15a1 to produce binding sites with higher affinity might be 
an improved delivery method for F5-peptide into the seminiferous epithelium where it functions as a 
potential male contraceptive.
At this point, we also question whether Slc15a1 is the only carrier for transporting F5-peptide into 
the seminiferous epithelium. We are taking it upon ourselves in a separate but closely related study, to 
investigate the involvement of Slc15a1 in F5-peptide induced BTB dynamic changes in cultured Sertoli 
cells, a different system from the in vivo one used in this study because no germ cells are present and 
F5-peptide is in fact treated apically instead of basally in vivo. We are particularly interested to determine 
whether the overexpression of Slc15a1 in Sertoli cells can promote the transient open of the permeability 
barrier by facilitating F5-peptide entry. We anticipate that further studies will provide new and impor-
tant insights on the dual role of Slc15a1 in nutrition absorption and cell junction dynamics. Additional 
studies are now warranted to investigate if Slc15a1 can be modified into a more suitable carrier with high 
transport capacity for F5-peptide, a potential male contraceptive, to assist it to enter the seminiferous epi-
thelium and exert functions. We expect that some of these questions will be addressed in the near future.
Materials and Methods
Animals. The animal procedure described in this study was approved by the Fourth Military Medical 
University Institutional Animal Use and Care Committee (Xi’an, China). Adult male Sprague-Dawley 
(SD) rats were obtained from Animal Center in the Fourth Military Medical University. Studies were per-
formed in accordance with the Guide for the Care and Use of Laboratory Animals defined by National 
Research Council (the National Academies, Eighth Edition, 2011). All rats were maintained at 22 °C with 
a 12/12-light/dark cycle and received lab chow and water ad libitum.
Testicular cell isolation. Primary Sertoli cells were isolated from the testes of 20-day-old SD rats as 
described previously22. It is noted that Sertoli cells isolated from rats at 20 days of age are fully differenti-
ated and cease to divide23. Sertoli cells were then plated on Matrigel (BD bioscience, San Jose, CA)-coated 
dishes at 0.5 × 106 cells/cm2 and cultured in serum-free F12/DMEM (Sigma-Aldrich, St. Louis, MO) 
supplemented with growth factors, bacitracin, and gentamicin at 35 °C in a humidified atmosphere with 
95% air/5% CO2 (v/v)22. Two days thereafter, Sertoli cells were subjected to hypotonic treatment to lyse 
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residual germ cells, as described previously24, so that these cultures had a Sertoli cell purity >98% and 
were contaminated with negligible Leydig and germ cells. Sertoli cells were then harvested for lysate 
preparation.
Total germ cells were isolated from testes of adult SD rats (∼ 250 g b. w./each) by a mechanical pro-
cedure without using trypsin and were not subjected to the glass-wool filtration step so that elongating/
elongated spermatids were retained in the germ cell population25. Total germ cells were plated on 100-mm 
dishes at 2.5 × 106 cells/ml and cultured in F12/DMEM supplemented with 2 mM sodium pyruvate and 
6 mM sodium DL-lactate as described previously25. Germ cells were harvested for lysate preparation after 
∼ 16 h in culture at 35 °C with a viability of greater than 95% by the erythrosine red dye exclusion test, 
as described previously26.
Leydig cells were isolated from adult SD rats and purified by discontinuous Percoll gradient as pre-
viously described27, while peritubular myoid cells were isolated from 20-day-old SD rats by sequential 
enzymatic digestion as described in28.
RNA extraction and RT-PCR. For RNA extraction, testes, Sertoli cells, and germ cells were lysed in 
TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. The extracted 
total RNA was reverse transcribed to cDNA using M-MLV reverse transcriptase (Promega, Madison, 
WI). The cDNAs of Slc15a1 and S-16 genes were amplified by PCR using GoTaq DNA polymerase 
(Promega) with specific primer pairs (Table 1). The authenticity of PCR products was verified by DNA 
sequencing.
Lysate preparation and immunoblotting. Lysates of testes, Sertoli cells, and germ cells were pre-
pared in IP lysis buffer: 50 mM Tris, pH 7.4 at 22 °C, containing 150 mM NaCl, 2 mM EGTA, 10% glycerol 
(v/v), 1% Nonidet P-40 (v/v), and freshly supplemented with protease inhibitor cocktail (Sigma-Aldrich) 
and phosphatase inhibitor cocktail 1 and cocktail 2 (Sigma-Aldrich) using a lysis buffer:inhibitor ratio 
(v/v) at 100:1. Immunoblotting was performed as described previously13 with a rabbit anti-Slc15a1 pri-
mary antibody (Table 2) using ~50 μ g protein lysates per sample for SDS-PAGE. Equal protein loading 
was assessed by stripping blots and re-probed with a goat anti-β -actin antibody (Table 2).
Immunohistochemistry and immunofluorescent staining. Frozen testis sections at 7-μ m thick-
ness obtained in a cryostat at − 20 °C were fixed with 4% paraformaldehyde (w/v) in PBS for 10 min at 
room temperature and permeabilized with 0.1% Triton X-100 (v/v) in PBS for 10 min at room tempera-
ture. Immunohistochemistry was carried out with a AEC Detection System kit (Millipore, Billerica, MA) 
according to the manufacturer’s instructions. For immunofluorescent staining, sections were blocked 
with 1% BSA (w/v) in PBS, to be followed by an overnight incubation of primary antibodies (Table 2) at 
1:50 dilution in PBS, and then a 30-min incubation of Alexa Fluor-conjugated (Alexa Fluor 488, green 
fluorescence; Alexa Fluor 555, red fluorescence) goat secondary antibodies (Invitrogen) at 1:200 dilution 
in PBS. Sections were mounted in ProLong Gold antifade reagent with DAPI (Invitrogen). To eliminate 
interexperimental variations, all cross sections of testes within a treatment group were mounted onto 
the same microscope slides and processed simultaneously. All staining experiments were repeated three 
times using different animals.
Treatment of rat testes with synthetic F5-peptide. Adult rats weighing ~250 g body weight 
(n = 3 rats per time point in each treatment group) received a single dose of synthetic F5-peptide (pep-
tide information is available in7) at 320 μ g per testis via direct intratesticular injection using a 28-gauge 
needle in a final injection volume of ~200 μ l (in 0.9% saline) as described earlier29,30. This concentration 
of synthetic F5-peptide was selected based on the in vitro results as reported earlier7. Rats were eutha-
nized by CO2 asphyxiation on selective time points and testes were removed. In selected experiments, 
testes were either fixed in Bouin’s fixative to be used for paraffin embedding and sectioning for hema-
toxylin and eosin staining for histological analysis as described31, or snap frozen in liquid nitrogen and 
stored at −80 °C until used to obtain testis lysates for immunofluorescence or immunoblotting.
Slc15a1 RNAi in adult rat testes in vivo. Adult male Sprague-Dawley rats (∼ 250 g b. w./each) were 
treated with non-targeting control or Slc15a1-specific siRNA transfection mix via intratesticular injection 
using a 28-gauge needle, as described previously29,30. To silence Slc15a1, four different siRNA sequences 
(J-095173-21: 5′ -CAGCAGAGAUCGAGGCACAtt; J-095173-22: 5′ -GCAUCAUAUUUGCCAUUAUtt; 
J-095173-23: 5′ -ACAAACAGUGGGCUGAGUAtt; J-095173-24: 5′ -CGUUGGAACCUGUCUCACAtt; 
Thermo Scientific) were analyzed and individually used. The ON-TARGETplus Non-targeting Pool 
(D-001810-10, Thermo Scientific) was used as control. Each transfection mix (final volume ∼ 200 μ l) 
consisted of 100 nM siRNA duplexes and 7.5 μ l Ribojuice siRNA transfection reagent (Invitrogen) sus-
pended in 190 μ l Opti-MEM (Invitrogen). The volume of each testis was assumed to be ∼ 1.6 ml. Different 
pilot experiments were performed to assess the optimal ratio of Opti-MEM to Ribojuice. Control and 
Slc15a1 RNAi transfection mix were administered to a different testis in the same rat, so that each animal 
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consisted of a control and a treated testis. Rats were terminated for western blotting analysis, histological 
analysis using paraffin sections, or in vivo BTB integrity assay at least two days after RNAi treatment.
Hematoxylin and eosin staining. Paraffin sections at 7-μ m thickness were obtained from Bouin’s 
fixed testes embedded in paraffin. After dewaxing with xylene, sections were stained with Hematoxylin 
7211 for 3 min, to be followed by 1-min incubation of Clarifier 1 and Bluing Reagent, and then stained 
with Eosin-Y for 30 s (reagents from Richard-Allan Scientific, Richland, MI). Results were analyzed in 
conjunction with 3 sets of frozen testis sections stained with DAPI in separate experiments to quantify 
the percentage of tubules displaying germ cell loss from the seminiferous epithelium.
BTB integrity assay. Each rat was under anesthesia with ketamine HCl (60 mg/kg b. w.) together 
with xylazine (10 mg/kg b. w.) administered i.m. Thereafter, a small incision on the skin over the jugular 
vein was made, and the vein was carefully exposed. About 1.5 mg FITC-conjugated inulin (Mr = 4.6 kD) 
(Sigma-Aldrich) in 300 μ l PBS was administered into the jugular vein using a 28-gauge needle. About 
30 min thereafter, rats were euthanized by CO2 asphyxiation. The integrity of the BTB was assessed by 
its ability to block inulin-FITC from entering the adluminal compartment, as visualized by fluorescent 
microscopy in frozen testis sections. Damaged tubules were defined herein by the penetration of green 
fluorescence across at least 3 layers of cells behind the BTB toward the tubule lumen.
Statistical analysis. Each experiment reported herein was repeated at least 3 times, excluding pilot 
experiments. Statistical analysis was performed using the GB-STAT software package (version 7.0; 
Dynamic Microsystems, Silver Spring, MD). For multiple comparisons, 1-way ANOVA was performed 
and followed by Dunnett’s test. This thus compared multiple treatment groups against the control. In 
selected experiments, Student’s t test was used for paired comparisons.
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